Justin Murray, PhDSenior Principal Scientist, Selection & Modality Engineering at Amgen, Inc.
Justin received his BSc in Chemistry from the Colorado School of Mines. He received his PhD from the University of Wisconsin - Madison under the direction of Prof. Sam Gellman for research on beta-peptide inhibitors of protein-protein interactions. He joined the Peptide Research & Discovery group at Amgen in 2006 and focused his research on disulfide-rich peptide inhibitors of ion channels and developed his interests in high-throughput synthesis, laboratory automation, and conjugation technologies. Now in the Selection & Modality Engineering group, Justin is working to establish oligonucleotide therapeutics as a new modality for Amgen.